| Company Name | # of Hedge Funds | # of Insiders Buying | # of Insiders Selling |
| Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) | 12 | 0 | 0 |
| Intercept Pharmaceuticals Inc (NASDAQ:ICPT) | 11 | 0 | 0 |
| Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) | 26 | 0 | 0 |
| Neurocrine Biosciences, Inc. (NASDAQ:NBIX) | 19 | 0 | 0 |
| Impax Laboratories Inc (NASDAQ:IPXL) | 22 | 0 | 0 |
Using the returns shown by the previously mentioned strategies, regular investors should always keep one eye on hedge fund and insider trading activity, and Pacira Pharmaceuticals Inc (NASDAQ:PCRX) is no exception.
Discover how hedge fund piggybacking can benefit you
Recommended Reading:
Here is What Hedge Funds Think About Pacira Pharmaceuticals Inc (PCRX)